1. Home
  2. CORT vs ONON Comparison

CORT vs ONON Comparison

Compare CORT & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$113.05

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo On Holding AG

ONON

On Holding AG

N/A

Current Price

$27.86

Market Cap

10.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
ONON
Founded
1998
2010
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.4B
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
CORT
ONON
Price
$113.05
$27.86
Analyst Decision
Buy
Strong Buy
Analyst Count
5
20
Target Price
$96.50
$60.15
AVG Volume (30 Days)
805.4K
9.0M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$761,407,000.00
N/A
Revenue This Year
$26.08
$19.58
Revenue Next Year
$26.98
$19.98
P/E Ratio
$1,259.44
$56.05
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$28.21
52 Week High
$126.38
$51.08

Technical Indicators

Market Signals
Indicator
CORT
ONON
Relative Strength Index (RSI) 51.71 27.11
Support Level $77.73 N/A
Resistance Level $122.21 $38.73
Average True Range (ATR) 4.04 0.91
MACD -1.68 -0.21
Stochastic Oscillator 15.22 1.93

Price Performance

Historical Comparison
CORT
ONON

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About ONON On Holding AG

Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.

Share on Social Networks: